Asia Pacific Major Report - A New Era Of Life Sciences Growth

June 17, 2021

Looking for a PDF of this content?

  • Asia Pacific is home to approximately 60% of the global population. The region includes the many of the world’s most populous and fastest-growing countries as well as several rapidly ageing societies.


  • Supported by expanding demand from a large and ageing population and a steady flow of M&A activity, recent years have seen the life sciences industry experience rapid growth in Asia Pacific.


  • Although global pharmaceutical giants from the U.S. and Europe continue to dominate the market, homegrown firms are expanding rapidly. Other key developments include the emergence of Asia Pacific life science clusters with the talent, infrastructure, facilities, manufacturing capacity and other critical environments required to meet the industry’s highly specialised demands.


  • This report by CBRE Research provides an overview of Asia Pacific life sciences real estate, focusing on the key trends, demand drivers, corporate real estate strategies and investment opportunities in the region’s major life sciences hubs.